Outpatient opioid use after minimally invasive surgery for lung cancer: a Surveillance, Epidemiology, and End Results-Medicare cohort study.

ABSTRACT:

Background

Opioids are commonly used for postoperative pain after lung resection. It is unclear whether opioid use differs between minimally invasive thoracoscopic approaches. We compared opioid use following robotic-assisted surgery (RAS) and video-assisted thoracoscopic surgery (VATS).

Methods

The Surveillance, Epidemiology, and End Results-Medicare claims database was queried for patients who underwent resection of non-small cell lung cancer (NSCLC) between January 2016 and July 2020. Outcomes included any opioid, abuse-potential (schedule II/III), and high-dose (≥50 morphine milligram equivalents/day) opioid fill, assessed across immediate (0-42 days), short-term (43-90 days), and long-term (91-180 days) periods. Inverse-probability of treatment weighted logistic regress

SUBMITTER: Murillo A 

PROVIDER: S-EPMC12688600 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature